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Synthesis of compounds 52 1-5 :
To a solution of anhydrous guanosine (0.56 g, 1.42 mmol) suspended in 30 mL of anhydrous DMF and 2 mL of dry pyridine was added dropwise 1,3-dichloro-1,1`,3,3`tetraisopropyldisiloxane (0.65 mL, 2.05 mmol). The mixture was allowed to stir for 5 h and then added slowly to 30 mL of vigorously stirred ice water. The resulting white precipitate was filtered, washed with water, and purified by flash column chromatography (Chloroform/Methanol 5%) yielding the silylether 48. Yield 0.7 g (70%). 1 A solution of 48 (0.54 g, 1.03 mmol) and 4-(dimethylamino)pyridine (0.25 g, 3.0 mmol) in pyridine (0.8 mL, 9.2 mmol)--Dichloromethane (20 mL) was cooled to 0 °C (1 h) and treated with trifluoromethanesulfonic anhydride (0.26 mL, 1.54 mmol). The mixture was allowed to stir at 0 °C for 5 min and then at room temperature for 3 h and finally partitioned between dichloromethane (10 mL) and water (10 mL). The organic layer was washed with water (2 x 20 mL), brine (2 x 20 mL) and finally dried over magnesium sulfate. Flash column chromatography (Hexane/ethylacetate 15%) yielded 49: 0.45 g (68%). 1 H NMR (CDCl 3 ) ppm 11.9 (s, NH amide), 7.8 (s, H8), 6.0 (s, NH2), 5 
9-(3ʹ′,5ʹ′-O-(1,1ʹ′,3,3ʹ′-Tetraisopropyldisiloxane-1,3-diyl) )-2ʹ′-chloro-2-deoxy-β-Darabinofuranosyl)guanine 3 50.
The trifluoromethanesulfonate 49 (0.3 g, 0.45 mmol) and lithium chloride (0.19 g, 4.5 mmol) were dissolved in 15 mL of dimethylformamide (DMF) and the solution was stirred at 50 o C for 30 min, then cooled to room temperature and stirred overnight at room temperature, the reaction was monitored by TLC in chloroforme/methanol (10:1). After removal of the solvent under reduced pressure, the residue was taken up in ethylacetate and washed with water. The aqueous phase were re-extracted twice with ethylacetate and the combined organic phase was dried over magnesium sulfate. After evaporation of the solvent and drying of the product in vacuum, the residue was purified by flash column chromatography (Hexane /ethylacetate 15%) yielding 50: 
9(2'-Chloro-2-deoxy-β-D-arabinofuranosyl)guanine 4 51.
Deprotection of the bifunctional silyl group: a 1 molar solution of tetra-n-butylammonium fluoride (2eq) was added to a solution of 50 in tetrahydrofuran (THF) at room temperature and the deprotection reaction was followed by TLC (CHCl 3 : MeOH, 5:1). The reaction was almost completed within 10 min. The reaction mixture was then concentrated under reduced pressure and the residue was purified by flash column chromatography (Chloroform/Methanol 5%). Figure S8 : 1 H NMR (MeOD, d 4 ) for 9(2'-Chloro-2-deoxy-β-D-arabinofuranosyl)guanine 51. 2'-Chloro-2'-deoxy-β-D-arabinofuranosyl-5`-monophosphate 5 52. A suspension of 9(2'-Chloro-2-deoxy-β-D-arabinofuranosyl)guanine 51, (50 mg, 0.18 mmol) in trimethylphosphate TEP, (0.6 mL) was heated at 50 o C for 15 min and then cooled to 0 o C. Water (1.6 uL, 0.09 mmol) was added followed by POCl 3 (33 uL, 0.35 mmol) at 0 o C, and the entire mixture was further stirred at 0 o C for 1.5 h. The mixture was poured into ice-water (1 mL) and stirred for another hour before it was neutralized with ammonium bicarbonate solution. The reaction mixture was lyophilized to give a white product which was then purified by Prep HPLC using a SPLC-18DB column (10 x 250 mm, 5 µ, Supelco) at a flow rate of 2 mL/min using an Agilent 100 HPLC system with quaternary pump and manual injector. 1 Figure S10 : Scheme for the synthesis of compound 57.
9-(3ʹ′,5ʹ′-O-(1,1ʹ′,3,3ʹ′-Tetraisopropyldisiloxane-1,3-diyl)-β-D-arabinofuranosyl) guanine 6 53.
Treatment of 0.44 g (0.80 mmol) of 3`,5`-O-(1,1`,3,3`-Tetraisopropyldisiloxane-1,3-diyl)-α-Dguanosine (48) with 2.3 equiv of Dess-Martin periodinane reagent, gave 0.4 g of a yellow glass whose 1 H NMR spectrum (DMSO-d6) indicated formation of the 2`-ketoguanosine derivative plus its hydrate. Reduction of this material with sodium borohydride afforded 9-(3`,5`-O-(1,1`,3,3`-Tetraisopropyldisiloxane-1,3-diyl) arabinofuranosy1)guanine which was purified by flash column chromatography (Chloroform/Methanol 5%). Yield 0.3 g (68%). 1 Figure S17 : 1 H NMR (MeOD, d 4 ) for 2'-Chloro-2'-deoxyguanosine 56. 2'-Chloro-2'-deoxyguanosine-5`-monophosphate 5 , 57. A suspension of 2'-chloro-2'-deoxyguanosine, 56 (50 mg, 0.177 mmol) in trimethylphosphate, (0.6 mL) was heated at 50 o C for 15 min and then cooled to 0 o C. Water (1.6 uL, 0.09 mmol) was added followed by POCl 3 (33uL, 0.35 mmol) at 0 o C, and the entire mixture was further stirred at 0 o C for 1.5 h. The mixture was poured into ice-water (1 mL) and stirred for another hour before it was neutralized with ammonium bicarbonate solution. The reaction mixture was lyophilized to give white product which was then purified by Prep HPLC using a SPLC-18DB column (10 x 250 mm, 5 µ, Supelco) at a flow rate of 2 mL/min using an Agilent 100 HPLC system with a quaternary pump and manual injector. 1H NMR (D 2 O) ppm 8.1 (s, H8), 6.25 (s, H1ʹ′), 4.55 (m, H3` and H4ʹ′), 4.3 (m, H2ʹ′), 4.0 (m, H5ʹ′ and H5ʹ′ʹ′). PPM Figure S19 : Scheme for the synthesis of reference compound 23.
5′-O-Tosylthymidine 7 58.
Tosylthymidine was prepared accodring to the literature procedure 7 and is summarized as follows. Briefly, thymidine (2.0 mmol) was treated with a 1.2 equivalents of p-TsCl in 15 mL dry pyridine at −5 °C. After 16 h at 0 °C, the reaction was quenched with ice−water and extracted with chloroform. The combined chloroform extracts were washed consecutively with saturated NaHCO 3 and water and dried over anhydrous 
5-(3-Mercaptobenzoic acid)-3-furanone 23.
3′-Keto-5′-tosylthymidine (100 mg, 0.25 mmol) was dissolved in 2.0 mL of chloroform, and 10 uL of purified triethylamine was added. After 10 min at room temperature, (48 mg, 0.3 mmol) of 3-mercaptobenzoic acid and 20 uL of triethylamine were added. The solvent was evaporated in vacuo at ambient temperature to give a crude material that was purified by silica gel column chromatography in (Methanol:Chloroform 5-10%). It was noticed that there is only one compound formed and isolated even if 3-mercaptobenzoic acid was added in excess. 1 HNMR (CDC1 3 Glacial acetic acid (30µL) was added to a mixture of d-glucose (1.08 g, 6mmol), p-toluidine (772 mg, 7 mmol) in water (1 mL). The mixture was rotated on a rotary evaporator (sealed without vacuum) at 90°C for 2 h (during this time the product precipitated from the reaction mixture). After cooling to room temperature, ether-ethanol (3:1, 20 mL) was added. Upon stirring at room temperature for an additional 2 h, the mixture was filtered, washed with ether (10 mL), etherethanol (5:1, 20 ml mL), ether (10 mL), and dried under vacuum to give aminoalcohol 61 as a light brownish white solid (0.6 g, 41% Glacial acetic acid (30µL) was added to a mixture of d-glucose (1.08 g, 6mmol), p-toluidine (772 mg, 7 mmol) in water (1 mL). The mixture was rotated on a rotary evaporator (sealed without vacuum) at 90°C for 2 h (during this time the product precipitated from the reaction mixture). After cooling to room temperature, ether-ethanol (3:1, 20 mL) was added. Upon stirring at room temperature for an additional 2 h, the mixture was filtered, washed with ether (10 mL), etherethanol (5:1, 20 ml mL), ether (10 mL), and dried under vacuum to give aminoalcohol X as a light brownish-white solid (0.63 g, 43%). 1H NMR (DMSO-d6) ) ppm 6.88 (d, 2H), 6 
2-Amino-6-((2R,3S)-2,3,4-trihydroxybutyl)pteridin-4(3H)-one 26.
A mixture of 2,5,6-triaminopyrimidin-4-ol (210 mg, 1.5 mmol), p-tolyl-D-isoglucosamine (198 mg, 0.73 mmol), sodium acetate (225 mg) and boric acid (60 mg) in water (5 ml) was heated in a stream of argon for 6 h on water bath. A grayish brown solid separated out. The product was filtered and washed with acetone (20 mL) and ethanol till the filtrate was colorless. This was followed by ether wash. The buff colored solid was dissolved in 1N HCl (30 ml). The solution was treated with charcoal and filtered to remove the charcoal. The resulting filtrate was neutralized with ammonia and the neutralized solution was left in the cold room overnight. This resulted in yellow precipitate, (0.1 g, 51% Contrary to the results described in this paper, a previous publication suggested that compound (8) is the product of MoaA 14 . Our studies on the MoaA reaction with 2',3'-dideoxyGTP resulted in the formation of compound (65), the oxidized, dideoxy analog of compound (8) 15 . The strategy that we used to identify compound (65) is shown in Figure S33(A) . MoaA reactions were run with 2',3'-dideoxyGTP as the substrate. Then the small molecule pool was treated with phosphatase followed by acid hydrolysis. The product was then compared with a synthetic standard to establish its identity. In order to test whether compound (8) was formed in the native MoaA catalyzed reaction with GTP as the substrate, a similar strategy was used. The small molecule pool was treated with phosphatase followed by acid hydrolysis. This mixture was then analyzed by LCMS ( Figure S34 
